# Benznidazole Absorption, Metabolism and Excretion Study

> **NCT03739541** · PHASE1 · COMPLETED · sponsor: **Exeltis France** · enrollment: 6 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** [14C]-Benznidazole

## Key facts

- **NCT ID:** NCT03739541
- **Lead sponsor:** Exeltis France
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-16
- **Primary completion:** 2018-09-02
- **Final completion:** 2018-09-02
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739541, "Benznidazole Absorption, Metabolism and Excretion Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03739541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*